Switch to: References

Add citations

You must login to add citations.
  1. Dual-use decision making: relational and positional issues.Nicholas G. Evans - 2014 - Monash Bioethics Review 32 (3-4):268-283.
    Debates about dual-use research often turn on the potential for scientific research to be used to benefit or harm humanity. This dual-use potential is conventionally understood as the product of the magnitude of the harms and benefits of dual-use research, multiplied by their likelihood. This account, however, neglects important social aspects of the use of science and technology. In this paper, I supplement existing conceptions of dual-use potential to account for the social context of dual-use research. This account incorporates relational (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • The Streetlight Effect: Regulating Genomics Where the Light Is.Barbara J. Evans - 2020 - Journal of Law, Medicine and Ethics 48 (1):105-118.
    Regulatory policy for genomic testing may be subject to biases that favor reliance on existing regulatory frameworks even when those frameworks carry unintended legal consequences or may be poorly tailored to the challenges genomic testing presents. This article explores three examples drawn from genetic privacy regulation, oversight of clinical uses of genomic information, and regulation of genomic software. Overreliance on expedient regulatory approaches has a potential to undercut complete and durable solutions.
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Editors' Overview: Forbidding Science? [REVIEW]Gary E. Marchant & Stephanie J. Bird - 2009 - Science and Engineering Ethics 15 (3):263-269.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Science and Science Policy: Regulating “Select Agents” in the Age of Synthetic Biology.Pierre-Olivier Méthot - 2015 - Perspectives on Science 23 (3):280-309.
    Just like atomic physics seventy years ago, when it was realized that chain reaction could lead to medical applications as well as to the creation of atomic weapons, the life sciences have entered a grey zone. “Advances in biotechnology […]” a 2003 CIA document stated, “have the potential to create a much more dangerous biological warfare threat […] Engineered biological agents could be much worse than any disease known to man”. As sociologists of science have noted, contemporary life sciences have (...)
    Download  
     
    Export citation  
     
    Bookmark